Literature DB >> 19917418

A survival case of ABO-incompatible liver transplantation complicated with severe preoperative infection and subsequent overwhelming postsplenectomy infection.

K Takeda1, D Morioka, T Kumamoto, K Matsuo, K Tanaka, I Endo, S Togo, H Shimada.   

Abstract

A 47-year-old Japanese man was transferred to our hospital because of acute-on-chronic hepatitis B virus infection. On admission, he was suffering from sepsis due to a catheter infection and respiratory failure caused by pulmonary edema and pneumonia, but, as a result of preoperative intensive care, we avoided septic shock. ABO-incompatible liver transplantation (ABO-I-LT) was performed. In accordance with our ABO-I-LT protocol, we administered, rituximab and performed plasma exchange, splenectomy as well as hepatic artery infusion. The patient was discharged 80 days after living donor transplantation (LDLT). However, 136 days after LDLT, he experienced recurrent respiratory failure due to severe pneumonia. At that time, the CD19(+) B-cell count in the peripheral blood flow remained below 1%. We suspected a mixed infection involving Streptococcus pneumonia, Pneumocystis carinii, and fungus. The cause of the complication was overwhelming postsplenectomy infection (OPSI). We started administration of sulfamethoxazole and trimethoprim, ciprofloxacin hydrochloride, and micafungin sodium therapy as well as gamma-globulin. Oxygenation improved gradually; the patient was discharged at 41 days after re-admission. Although this patient survived the OPSI, it was clear that some aspects of the ABO-I-LT protocol should also be altered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917418     DOI: 10.1016/j.transproceed.2009.02.094

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute.

Authors:  Naoya Yamada; Yukihiro Sanada; Yuta Hirata; Noriki Okada; Yoshiyuki Ihara; Hideki Sasanuma; Taizen Urahashi; Yasunaru Sakuma; Yoshikazu Yasuda; Koichi Mizuta
Journal:  Pediatr Surg Int       Date:  2016-01-19       Impact factor: 1.827

2.  Successful multidisciplinary treatment of refractory cytomegalovirus infection after living donor liver transplantation using mixed lymphocyte reactions: report of a case.

Authors:  Kazuhisa Takeda; Yu Sawada; Takafumi Kumamoto; Ryusei Matsuyama; Yuka Tanaka; Hideki Ohdan; Itaru Endo
Journal:  Clin J Gastroenterol       Date:  2016-02-18

3.  Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: A case report.

Authors:  Hui-Bin Huang; Jing-Min Peng; Bin Du
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

Review 4.  Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.

Authors:  Xuqin Jiang; Xiaodong Mei; Di Feng; Xiaojing Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

5.  Emergency versus elective living-donor liver transplantation: a comparison of a single center analysis.

Authors:  Kazuhisa Takeda; Kuniya Tanaka; Takafumi Kumamoto; Kazunori Nojiri; Ryutaro Mori; Koichi Taniguchi; Ryusei Matsuyama; Itaru Endo
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

6.  Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection.

Authors:  Kensuke Nakamura; Yuji Takahashi; Tomohiro Sonoo; Hideki Hashimoto
Journal:  J Glob Infect Dis       Date:  2021-01-29

7.  Septic pulmonary embolism originated from subcutaneous abscess after living donor liver transplantation: a pitfall of postoperative management.

Authors:  Kazuhisa Takeda; Kuniya Tanaka; Takafumi Kumamoto; Kazunori Nojiri; Ryutaro Mori; Koichi Taniguchi; Ryusei Matsuyama; Hideaki Kato; Itaru Endo
Journal:  Clin J Gastroenterol       Date:  2013-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.